From: Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
Characteristics | (n) |
---|---|
Country | |
 HIC | 26 |
 UMIC | 3 |
 LMIC | 5 |
 LIC | 0 |
 HIC & UMIC | 1 |
 HIC & LMIC | 1 |
 HIC, UMIC, LMIC | 1 |
 HIC, UMIC, LMIC & LIC | 3 |
 Theoretical | 1 |
 Not clear | 1 |
Model features | |
 Deterministic, compartmental | 28 |
 Agent-based (stochastic or deterministic) | 6 |
 Stochastic, compartmental | 4 |
 Deterministic, delay differential equation | 1 |
 Linear | 1 |
 Unclear | 3 |
Model structure | |
 SEIR | 11 |
 Expanded SEIR | 19 |
 SIR | 1 |
 Expanded SIR | 5 |
 SAPHIRE | 1 |
 Unclear natural history | 5 |
Contact matrix | |
 Age | 22 |
 Age & essential worker status | 1 |
 Age & day-specific | 1 |
 Age & location | 1 |
 Age, antibody status, major nationalities | 1 |
 Occupation, age, location & intensity of interaction | 1 |
 Social contact network | 3 |
 Vulnerable, front-line workers, non-vulnerable | 1 |
 Homogeneous mixing | 2 |
 Geographic mapping and socio-economic status | 1 |
 Age, comorbidities, vaccination status | 1 |
 Jurisdiction contact rate (invariant with age) | 1 |
 Unclear | 7 |
Outcomes modelled | |
 Deaths | 34 |
 Cases | 27 |
 Hospitalisations | 11 |
 ICU admission | 6 |
 No of vx to avert one infection | 1 |
 Loss of economic benefits | 1 |
 Years of life lost | 3 |
 QALYs | 2 |
 DALYs | 1 |
 Cost-effectiveness ratio | 1 |
 Net present value of damages (VSL & DALYs) | 1 |
 Infection attack rate | 2 |
 Peak infections | 1 |
 Risk of new wave | 1 |
 Life-years gained | 1 |
 Total cost | 2 |
 Net monetary benefits | 1 |
 Effective reproductive number | 1 |
 Herd immunity | 1 |